- Home
- APLT vs AVNS Comparison
APLT vs AVNS Comparison
Compare APLT & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AVNS
- Stock Information
- Founded
- APLT 2016
- AVNS 2014
- Country
- APLT United States
- AVNS United States
- Employees
- APLT N/A
- AVNS N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AVNS Industrial Specialties
- Sector
- APLT Health Care
- AVNS Health Care
- Exchange
- APLT Nasdaq
- AVNS Nasdaq
- Market Cap
- APLT 52.9M
- AVNS 591.9M
- IPO Year
- APLT 2019
- AVNS N/A
- Fundamental
- Price
- APLT $0.33
- AVNS $12.35
- Analyst Decision
- APLT Buy
- AVNS
- Analyst Count
- APLT 7
- AVNS 0
- Target Price
- APLT $6.10
- AVNS N/A
- AVG Volume (30 Days)
- APLT 2.3M
- AVNS 422.0K
- Earning Date
- APLT 08-06-2025
- AVNS 07-30-2025
- Dividend Yield
- APLT N/A
- AVNS N/A
- EPS Growth
- APLT N/A
- AVNS N/A
- EPS
- APLT N/A
- AVNS N/A
- Revenue
- APLT $265,000.00
- AVNS $689,200,000.00
- Revenue This Year
- APLT $1,768.13
- AVNS N/A
- Revenue Next Year
- APLT $292.85
- AVNS $3.42
- P/E Ratio
- APLT N/A
- AVNS N/A
- Revenue Growth
- APLT N/A
- AVNS 1.34
- 52 Week Low
- APLT $0.30
- AVNS $11.75
- 52 Week High
- APLT $10.62
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- APLT 43.25
- AVNS 49.86
- Support Level
- APLT $0.30
- AVNS $12.00
- Resistance Level
- APLT $0.36
- AVNS $12.83
- Average True Range (ATR)
- APLT 0.03
- AVNS 0.30
- MACD
- APLT -0.00
- AVNS 0.04
- Stochastic Oscillator
- APLT 22.22
- AVNS 58.44
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.